• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲苯达唑治疗棘球蚴病的化疗:7例患者的临床观察

Chemotherapy of echinococcosis with mebendazole: clinical observations of 7 patients.

作者信息

Kern P, Dietrich M, Volkmer K J

出版信息

Tropenmed Parasitol. 1979 Mar;30(1):65-72.

PMID:375511
Abstract

The effect of high dosage therapy with Mebendazole was studied in 5 patients with cystic echinococcosis and 2 patients with alveolar echinococcosis involving several organs. Follow-up studies at regular intervals from 7 to 20 months indicated an improvement of the pathological findings initially observed. This could clearly be demonstrated by the radiographic findings in cases with pulmonary involvement. The desintegration or dissolution of pulmonary cysts was observed within a few months after treatment with Mebendazole had begun. However, consolidation of previously emptied cysts occurred during the follow-up later. Allergic reactions were observed after commencement of drug therapy in two cases. These were probably due to spillage of antigenic material. The following treatment periods were tolerated well. No serious toxic side effects were observed in the other cases described here.

摘要

对5例囊性棘球蚴病患者和2例累及多个器官的泡状棘球蚴病患者进行了甲苯达唑高剂量疗法的疗效研究。在7至20个月的定期随访研究表明,最初观察到的病理结果有所改善。这在肺部受累病例的影像学检查结果中得到了明确证实。在用甲苯达唑治疗开始后的几个月内,观察到肺囊肿的崩解或溶解。然而,在随后的随访中,先前排空的囊肿出现了实变。在两例患者药物治疗开始后观察到过敏反应。这可能是由于抗原性物质的溢出所致。以下治疗期耐受性良好。在此描述的其他病例中未观察到严重的毒副作用。

相似文献

1
Chemotherapy of echinococcosis with mebendazole: clinical observations of 7 patients.甲苯达唑治疗棘球蚴病的化疗:7例患者的临床观察
Tropenmed Parasitol. 1979 Mar;30(1):65-72.
2
[Chemotherapy of human echinococcosis with mebendazole (Vermox): preliminary clinical results].[甲苯达唑(肠虫清)治疗人体棘球蚴病的初步临床结果]
Schweiz Med Wochenschr. 1979 Feb 3;109(5):148-51.
3
Treatment of human echinococcosis with mebendazole. Preliminary observations in 28 patients.用甲苯达唑治疗人体棘球蚴病。28例患者的初步观察。
Hepatogastroenterology. 1982 Dec;29(6):236-9.
4
[The mebendazole treatment of patients with alveolar echinococcosis].[甲苯达唑治疗泡型棘球蚴病患者]
Med Parazitol (Mosk). 1993 Mar-Apr(2):14-6.
5
[Value of high-dosage mebendazole chemotherapy in echinococcosis].[高剂量甲苯咪唑化疗在棘球蚴病中的价值]
Aktuelle Probl Chir Orthop. 1982;23:104-5.
6
[Treatment of hepatic and pulmonary echinococcosis with mebendazole (Vermox)].用甲苯咪唑(肠虫清)治疗肝和肺棘球蚴病
Vutr Boles. 1987;26(6):61-8.
7
[Treatment of echinococcosis with mebendazole (Vermox) in a patient with multiple cysts].[用甲苯达唑(肠虫清)治疗一名患有多个囊肿的棘球蚴病患者]
Ned Tijdschr Geneeskd. 1983 Mar 5;127(10):423-8.
8
[Agranulocytosis--a complication of the chemotherapy of echinococcosis with mebendazole].[粒细胞缺乏症——甲苯达唑治疗棘球蚴病化疗的一种并发症]
Med Parazitol (Mosk). 1992 Sep-Dec(5-6):9-11.
9
Editorial response: Treatment of cystic echinococcosis--improving but still limited.编辑回应:囊性棘球蚴病的治疗——虽有改善但仍有限。
Clin Infect Dis. 1999 Aug;29(2):310-1. doi: 10.1086/520206.
10
[The efficacy of the mebendazole treatment of patients with hydatid disease].[甲苯咪唑治疗包虫病患者的疗效]
Med Parazitol (Mosk). 1993 Jul-Sep(4):15-7.

引用本文的文献

1
Synthesis, characterization and , biological evaluations of substituted benzimidazole derivatives.取代苯并咪唑衍生物的合成、表征及生物学评价
Saudi J Biol Sci. 2022 Jan;29(1):239-250. doi: 10.1016/j.sjbs.2021.08.082. Epub 2021 Aug 28.
2
Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.人包虫病(囊型和泡型)的药物治疗进展:化合物和治疗靶点。
PLoS Negl Trop Dis. 2018 Apr 20;12(4):e0006422. doi: 10.1371/journal.pntd.0006422. eCollection 2018 Apr.
3
Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.
评价奥芬达唑、吡喹酮和阿苯达唑治疗囊型包虫病的效果:一项自然感染绵羊的随机临床试验。
PLoS Negl Trop Dis. 2010 Feb 23;4(2):e616. doi: 10.1371/journal.pntd.0000616.
4
Echinococcus granulosus infection: clinical presentation, medical treatment and outcome.细粒棘球绦虫感染:临床表现、医学治疗及结果
Langenbecks Arch Surg. 2003 Dec;388(6):413-20. doi: 10.1007/s00423-003-0418-y. Epub 2003 Nov 5.
5
Plasma concentrations of mebendazole during treatment of echinococcosis: preliminary results.甲苯达唑治疗包虫病期间的血浆浓度:初步结果
Eur J Clin Pharmacol. 1980 May;17(5):375-8. doi: 10.1007/BF00558451.
6
Effect of mebendazole against Echinococcus granulosus and Taenia hydatigena cysts in naturally infected sheep and relevance to larval tapeworm infections in man.甲苯咪唑对自然感染绵羊体内细粒棘球绦虫和泡状带绦虫囊肿的作用及其与人类幼虫绦虫感染的相关性
Z Parasitenkd. 1981;64(2):135-47. doi: 10.1007/BF00930490.
7
Chemotherapy of alveolar echinococcosis. Comparison of plasma mebendazole concentrations in animals and man.泡型包虫病的化疗。动物与人血浆中甲苯达唑浓度的比较。
Eur J Clin Pharmacol. 1981;20(6):427-33. doi: 10.1007/BF00542095.
8
Identification of biliary metabolites of mebendazole in the rat.大鼠体内甲苯达唑胆汁代谢物的鉴定。
Eur J Drug Metab Pharmacokinet. 1982;7(2):131-6. doi: 10.1007/BF03188730.
9
Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease.高剂量甲苯咪唑在治疗囊尾蚴病患者中的临床药代动力学
Eur J Clin Pharmacol. 1982;22(2):161-9. doi: 10.1007/BF00542462.
10
Echinococcus granulosus: the influence of mebendazole therapy on the ultrastructural morphology of the germinal layer of hydatid cysts in humans and mice.细粒棘球绦虫:甲苯达唑治疗对人和小鼠包虫囊肿生发层超微结构形态的影响
Z Parasitenkd. 1982;67(1):55-65. doi: 10.1007/BF00929514.